Ginès P, Krag A, Abraldes JG, Solà E, Fabrellas N, Kamath PS. Liver cirrhosis. Lancet. 2021;398:1359–76.

Article  PubMed  Google Scholar 

Berumen J, Baglieri J, Kisseleva T, Mekeel K. Liver fibrosis: pathophysiology and clinical implications. Wires Mech Dis. 2021;13: e1499.

Article  CAS  PubMed  Google Scholar 

Lafoz E, Ruart M, Anton A, Oncins A, Hernández-Gea V. The endothelium is a driver of liver fibrosis and regeneration. Cells. 2020;9:929.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Tsuchida T, Friedman SL. Mechanisms of hepatic stellate cell activation. Nat Rev Gastroenterol Hepatol. 2017;14:397–411.

Article  CAS  PubMed  Google Scholar 

Roehlen N, Crouchet E, Baumert TF. Liver fibrosis: mechanistic concepts and therapeutic perspectives. Cells. 2020; 9.

Acharya P, Chouhan K, Weiskirchen S, Weiskirchen R. Cellular mechanisms of liver fibrosis. Front Pharmacol. 2021;12: 671640.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Zadorozhna M, Di Gioia S, Conese M, Mangieri D. Neovascularization is a key feature of liver fibrosis progression: anti-angiogenesis as an innovative way of liver fibrosis treatment. Mol Biol Rep. 2020;47:2279–88.

Article  CAS  PubMed  Google Scholar 

Gong J, Tu W, Liu J, Tian D. Hepatocytes: a key role in liver inflammation. Front Immunol. 2022;13:1083780.

Article  CAS  PubMed  Google Scholar 

Kisseleva T, Brenner D. Molecular and cellular mechanisms of liver fibrosis and its regression. Nat Rev Gastroenterol Hepatol. 2021;18:151–66.

Article  PubMed  Google Scholar 

DuMond A, Pagès G. Neuropilins, as relevant oncology target: their role in the tumoral microenvironment. Front Cell Dev Biol. 2020;8:662.

Article  PubMed  PubMed Central  Google Scholar 

Fernández-Palanca P, Payo-Serafín T, Méndez-Blanco C, San-Miguel B, Tuñón MJ, González-Gallego J, Mauriz JL. Neuropilins as potential biomarkers in hepatocellular carcinoma: a systematic review of basic and clinical implications. Clin Mol Hepatol. 2023;29:293–319.

Article  PubMed  PubMed Central  Google Scholar 

Ellis LM. The role of neuropilins in cancer. Mol Cancer Ther. 2006;5:1099–107.

Article  CAS  PubMed  Google Scholar 

Li L, Jiang X, Zhang Q, Dong X, Gao Y, He Y, Qiao H, Xie F, Xie X, Sun X. Neuropilin-1 is associated with clinicopathology of gastric cancer and contributes to cell proliferation and migration as multifunctional co-receptors. J Exp Clin Cancer Res. 2016;35:16.

Article  PubMed  PubMed Central  Google Scholar 

Hu C, Jiang X. Role of NRP-1 in VEGF-VEGFR2-independent tumorigenesis. Target Oncol. 2016;11:501–5.

Article  PubMed  Google Scholar 

Colotti G, Failla CM, Lacal PM, Ungarelli M, Ruffini F, Di Micco P, Orecchia A, Morea V. Neuropilin-1 is required for endothelial cell adhesion to soluble vascular endothelial growth factor receptor 1. FEBS J. 2022;289:183–98.

Article  CAS  PubMed  Google Scholar 

Yang J, Guo Z, Song M, Pan Q, Zhao J, Huang Y, Han Y, Ouyang D, Yang C, Chen H, Di M. Lenvatinib improves anti-PD-1 therapeutic efficacy by promoting vascular normalization via the NRP-1-PDGFRbeta complex in hepatocellular carcinoma. Front Immunol. 2023;14:1212577.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Cao S, Yaqoob U, Das A, Shergill U, Jagavelu K, Huebert RC, Routray C, Abdelmoneim S, Vasdev M, Leof E, Charlton M. Neuropilin-1 promotes cirrhosis of the rodent and human liver by enhancing PDGF/TGF-beta signaling in hepatic stellate cells. J Clin Invest. 2010;120:2379–94.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Wang LE, Feng Y, Xie X, Wu H, Su XN, Qi J, Xin W, Gao L, Zhang Y, Shah VH, Zhu Q. Neuropilin-1 aggravates liver cirrhosis by promoting angiogenesis via VEGFR2-dependent PI3K/Akt pathway in hepatic sinusoidal endothelial cells. EBioMedicine. 2019;43:525–36.

Article  PubMed  PubMed Central  Google Scholar 

Xu J, Xia J. NRP-1 silencing suppresses hepatocellular carcinoma cell growth in vitro and in vivo. Exp Ther Med. 2013;5:150–4.

Article  CAS  PubMed  Google Scholar 

Xun LI, Yongqiang ZH, JinJing HU, Zhongtian BA, Wenbo ME, Xiaojing SO, Yongjian WE, Jun YA, Yihua ZH. Loss of neuropilin 1 inhibits liver cancer stem cells population and blocks metastasis in hepatocellular carcinoma via epithelial-mesenchymal transition. Neoplasma. 2021;68:325–33.

Article  Google Scholar 

Wu Q, Pan C, Zhou Y, Wang S, Xie L, Zhou W, Ding L, Chen T, Qian J, Su R, Gao X. Targeting neuropilin-1 abolishes anti-PD-1-upregulated regulatory T cells and synergizes with 4–1BB agonist for liver cancer treatment. Hepatology. 2023;78:1402–17.

Article  PubMed  Google Scholar 

Fu J, Su X, Li Z, Deng L, Liu X, Feng X, Peng J. HGF/c-MET pathway in cancer: from molecular characterization to clinical evidence. Oncogene. 2021;40:4625–51.

Article  CAS  PubMed  Google Scholar 

Goyal L, Muzumdar MD, Zhu AX. Targeting the HGF/c-MET pathway in hepatocellular carcinoma. Clin Cancer Res. 2013;19:2310–8.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Zhao Y, Ye W, Wang YD, Chen WD. HGF/c-met: A key promoter in liver regeneration. Front Pharmacol. 2022;13: 808855.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Tekkesin N, Taga Y, Sav A, Almaata I, İbrisim D. Induction of HGF and VEGF in hepatic regeneration after hepatotoxin-induced cirrhosis in mice. Hepatogastroenterology. 2011;58:971–9.

CAS  PubMed  Google Scholar 

Hoffmann K, Nagel AJ, Tanabe K, Fuchs J, Dehlke K, Ghamarnejad O, Lemekhova A, Mehrabi A. Markers of liver regeneration-the role of growth factors and cytokines: a systematic review. BMC Surg. 2020;20:31.

Article  PubMed  PubMed Central  Google Scholar 

Gupta G, Al-Malki WH, Kazmi I, Thangavelu L, Gupta PK, Jha NK, Prasher P, Singh SK, Dua K. The role of HGF/MET in liver cancer. Future Med Chem. 2021;13:1829–32.

Article  CAS  PubMed  Google Scholar 

Burbano de Lara S, Kemmer S, Biermayer I, Feiler S, Vlasov A, D’Alessandro LA, Helm B, Mölders C, Dieter Y, Ghallab A, Hengstler JG. Basal MET phosphorylation is an indicator of hepatocyte dysregulation in liver disease. Mol Syst Biol. 2024; 20:187–216.

Zhang T, Wang Y, Xie M, Ji X, Luo X, Chen X, Zhang B, Liu D, Feng Y, Sun M, Huang W. HGF-mediated elevation of ETV1 facilitates hepatocellular carcinoma metastasis through upregulating PTK2 and c-MET. J Exp Clin Cancer Res. 2022;41:275.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Wang H, Rao B, Lou J, Li J, Liu Z, Li A, Cui G, Ren Z, Yu Z. The function of the HGF/c-met axis in hepatocellular carcinoma. Front Cell Dev Biol. 2020;8:55.

Article  CAS  PubMed  PubMed Central  Google Scholar 

García-Vilas JA, Medina MÁ. Updates on the hepatocyte growth factor/c-Met axis in hepatocellular carcinoma and its therapeutic implications. World J Gastroenterol. 2018;24:3695–708.

Article  PubMed  PubMed Central  Google Scholar 

Charni-Natan M, Goldstein I. Protocol for primary mouse hepatocyte isolation. Star Protoc. 2020;1: 100086.

Article  PubMed  PubMed Central  Google Scholar